Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
CHEMISTRY REAGENTS is a federal award for 262-Network Contract Office 22 (36C262) held by Ortho-Clinical Diagnostics, Inc. Estimated value $2.8M ($1M obligated). Current period of performance ends Feb 28, 2023. Last award drew 4 bidders. Place of performance: LONG BEACH CA.
Recompete timing
PublicCurrent PoP ended Feb 28, 2023 (1311 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on 36C26221F0240? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordOrtho-Clinical Diagnostics, Inc — $57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C26221F0240?
36C26221F0240 (Chemistry reagents) is a 262-Network Contract Office 22 (36C262) award with a potential value of $2.8M, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C262-21-F-0240?
36C262-21-F-0240 is the dashed form of PIID 36C26221F0240 (Chemistry reagents), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C26221F0240?
262-Network Contract Office 22 (36C262) awarded 36C26221F0240 to Ortho-Clinical Diagnostics, Inc (potential $2.8M).
Who is the incumbent on 36C26221F0240?
Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Feb 28, 2023.
When does Ortho-Clinical Diagnostics, Inc’s 36C26221F0240 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 28, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C26221F0240? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.